# HIV-1 Vpr is targeted for degradation by autophagy

**Authors:** Yuexuan Chen, Susanne Klute, Anju Bansal, Konstantin Maria Johannes Sparrer, Ruth Serra-Moreno, Edward Campbell, Edward Campbell, Edward Campbell, Edward Campbell

PMC · DOI: 10.1371/journal.ppat.1014020 · PLOS Pathogens · 2026-03-02

## TL;DR

The HIV-1 protein Vpr is targeted for destruction by the cell's autophagy system, and its susceptibility to this process affects how the virus spreads.

## Contribution

Identifies HIV-1 Vpr as a novel autophagy target and shows that Vpr susceptibility to autophagy impacts HIV-1 spread.

## Key findings

- HIV-1 Vpr from the NL4–3 strain is targeted for autophagy, while Vpr from transmitted/founder viruses is resistant.
- Specific residues in NL4–3 Vpr affect its interaction with autophagy receptors like NDP52, SQSTM1/p62, and TAX1BP1.
- Viruses with autophagy-sensitive Vpr show reduced spread in 2D and 3D in vitro systems.

## Abstract

Autophagy is part of the innate immune arsenal to fight viruses, including HIV-1. We previously reported that HIV-1 Gag is targeted for autophagy-mediated degradation. Here, we identify HIV-1 Vpr, an important virulence factor, as an autophagy target in HIV-1 NL4–3, a lab adapted molecular clone. Notably, Vpr proteins from a collection of transmitted/founder viruses (TFVs) were resistant to autophagy. Based on this observation, we identified residues at positions 37, 45, 77, 83–86, 93–94 in NL4–3 Vpr as responsible for its susceptibility to autophagy. Importantly, differences between NL4–3 and TFV Vpr proteins at these positions impact their interaction with the autophagy receptors NDP52, SQSTM1/p62 and TAX1BP1. By engineering NL4–3 molecular clones harboring either autophagy-sensitive or -resistant vpr, we found that in 2D and 3D in vitro systems virus spread was significantly reduced for the virus carrying autophagy-sensitive Vpr. In conclusion, our study identifies Vpr as a novel autophagy target and suggests that Vpr susceptibility to autophagy impacts HIV-1 spread.

Autophagy is a cellular process essential for homeostasis, but also serves as a potent defense mechanism against intracellular pathogens, including viruses. We previously reported that the HIV-1 structural protein Gag (precursor of the virus capsid) is targeted by autophagy for elimination. However, the virus has evolved the accessory protein Nef to antagonize autophagy. In this study, we identify the HIV-1 accessory protein Vpr as another autophagy target and uncovered the autophagy receptors SQSTM1, TAX1BP1 and NDP52 as responsible for targeting Vpr to autophagosomes. Remarkably, we found that Vpr proteins of transmitted/founder viruses are resistant to autophagy, suggesting that autophagy resistance of Vpr might promote virus spread.

## Linked entities

- **Genes:** vpr (Vpr) [NCBI Gene 155807], gag (Pr55(Gag)) [NCBI Gene 155030], S100B (S100 calcium binding protein B) [NCBI Gene 6285], CALCOCO2 (calcium binding and coiled-coil domain 2) [NCBI Gene 10241], SQSTM1 (sequestosome 1) [NCBI Gene 8878], TAX1BP1 (Tax1 binding protein 1) [NCBI Gene 8887]
- **Proteins:** vpr (Vpr), gag (Pr55(Gag)), S100B (S100 calcium binding protein B), CALCOCO2 (calcium binding and coiled-coil domain 2), sqstm1 (sequestosome 1), TAX1BP1 (Tax1 binding protein 1)

## Full-text entities

- **Genes:** CD28 (CD28 molecule) [NCBI Gene 940] {aka IMD123, Tp44}, ITIH4 (inter-alpha-trypsin inhibitor heavy chain 4) [NCBI Gene 3700] {aka GP120, H4P, IHRP, ITI-HC4, ITIHL1, PK-120}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, ACTB (actin beta) [NCBI Gene 60] {aka BKRNS, BNS, BRWS1, CSMH, DDS1, PS1TP5BP1}, BP1 [NCBI Gene 474256], TAX1BP1 (Tax1 binding protein 1) [NCBI Gene 8887] {aka CALCOCO3, T6BP, TXBP151}, CALCOCO2 (calcium binding and coiled-coil domain 2) [NCBI Gene 10241] {aka NDP52}, MAP1LC3B (microtubule associated protein 1 light chain 3 beta) [NCBI Gene 81631] {aka ATG8F, LC3B, MAP1A/1BLC3, MAP1LC3B-a}, gag (Pr55(Gag)) [NCBI Gene 155030], TAT (tyrosine aminotransferase) [NCBI Gene 6898], env [NCBI Gene 155971], MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, CCR5 (C-C motif chemokine receptor 5) [NCBI Gene 1234] {aka CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, CTD (Coats disease) [NCBI Gene 1283], ATG5 (autophagy related 5) [NCBI Gene 9474] {aka APG5, APG5-LIKE, APG5L, ASP, SCAR25, hAPG5}, SQSTM1 (sequestosome 1) [NCBI Gene 8878] {aka A170, DMRV, EBIAP, FTDALS3, NADGP, OSIL}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, PIK3R3 (phosphoinositide-3-kinase regulatory subunit 3) [NCBI Gene 8503] {aka p55, p55-GAMMA, p55PIK}, BECN1 (beclin 1) [NCBI Gene 8678] {aka ATG6, VPS30, beclin1}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, FOXO3 (forkhead box O3) [NCBI Gene 2309] {aka AF6q21, FKHRL1, FKHRL1P2, FOXO2, FOXO3A}, CNTN2 (contactin 2) [NCBI Gene 6900] {aka AXT, EPEO5, FAME5, TAG-1, TAX, TAX1}, Nef [NCBI Gene 156110], ATG7 (autophagy related 7) [NCBI Gene 10533] {aka APG7-LIKE, APG7L, GSA7, SCAR31}, RUBCN (rubicon autophagy regulator) [NCBI Gene 9711] {aka KIAA0226, RUBICON, SCAR15}, PIK3C3 (phosphatidylinositol 3-kinase catalytic subunit type 3) [NCBI Gene 5289] {aka VPS34, Vps34, hVps34}, PRDX2 (peroxiredoxin 2) [NCBI Gene 7001] {aka HEL-S-2a, NKEF-B, NKEFB, PRP, PRX2, PRXII}, BNIP3L (BCL2 interacting protein 3 like) [NCBI Gene 665] {aka BNIP3a, NIP3L, NIX}, ATG12 (autophagy related 12) [NCBI Gene 9140] {aka APG12, APG12L, FBR93, HAPG12}, Vpu [NCBI Gene 155945], vpr (Vpr) [NCBI Gene 155807], MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) [NCBI Gene 84557] {aka ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, TFEB (transcription factor EB) [NCBI Gene 7942] {aka ALPHATFEB, BHLHE35, TCFEB}, TMED2 (transmembrane p24 trafficking protein 2) [NCBI Gene 10959] {aka P24A, RNP24, p24, p24b1, p24beta1}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, IL12B (interleukin 12B) [NCBI Gene 3593] {aka CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF}, MT4 (metallothionein 4) [NCBI Gene 84560] {aka MT-4, MT-IV, MTIV}, vif (Vif) [NCBI Gene 155459]
- **Diseases:** toxicity (MESH:D064420), Infection (MESH:D007239), MINOR (MESH:D004832), HIV infection (MESH:D015658), WT (MESH:D006969)
- **Chemicals:** acetone (MESH:D000096), amino acids (MESH:D000596), HEPES (MESH:D006531), Penicillin (MESH:D010406), puromycin (MESH:D011691), Hydroxychloroquine (MESH:D006886), PE (MESH:C483858), CH077 (-), Chlor (MESH:D002738), DMSO (MESH:D004121), DAPI (MESH:C007293), PVDF (MESH:C024865), SAR405 (MESH:C000594652), TexasRed (MESH:C034657), paraformaldehyde (MESH:C003043), L-glutamine (MESH:D005973), polyacrylamide (MESH:C016679), Rapamycin (MESH:D020123), Streptomycin (MESH:D013307), Triton X-100 (MESH:D017830), TAK-243 (MESH:C000622638), DPBS (MESH:C012939), methanol (MESH:D000432), BafA1 (MESH:C040929), SDS (MESH:D012967), calcium chloride (MESH:D002122), PtdIns3P (MESH:C055525), MG132 (MESH:C072553)
- **Species:** Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus (species) [taxon 12721], Simian immunodeficiency virus (no rank) [taxon 11723], Vesicular stomatitis virus (species) [taxon 11276], Human immunodeficiency virus 2 (no rank) [taxon 11709], Qubevirus faecium (species) [taxon 39804], Human immunodeficiency virus 1 (no rank) [taxon 11676]
- **Mutations:** P154G, Y45, N31F, K27M, S1430S, Alanine substitutions at residues 48, I37P, H45, Lysine by a Methionine, P60A, T2A, I61T, H45Y
- **Cell lines:** BaL — Mus musculus (Mouse), Mouse lymphoma, Transformed cell line (CVCL_9474), Jurkat CD4+ — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_AR84), JR-FL — Homo sapiens (Human), Oligodendroglioma, Cancer cell line (CVCL_B1D4), Jurkat — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_0065), pNL4-3 — Anopheles gambiae (African malaria mosquito), Spontaneously immortalized cell line (CVCL_Z622), NL4-3 — Neodiprion lecontei (Redheaded pine sawfly), Spontaneously immortalized cell line (CVCL_Z498), HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), BJ — Homo sapiens (Human), Telomerase immortalized cell line (CVCL_6573), T — Homo sapiens (Human), Esophageal squamous cell carcinoma, Cancer cell line (CVCL_3174), VK2 — Homo sapiens (Human), Transformed cell line (CVCL_6471), T/F Vpr — Homo sapiens (Human), Adult T-cell leukemia/lymphoma, Cancer cell line (CVCL_B7P1), CH077 — Homo sapiens (Human), Melanoma, Cancer cell line (CVCL_EI55)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12970978/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12970978/full.md

## References

110 references — full list in the complete paper: https://tomesphere.com/paper/PMC12970978/full.md

---
Source: https://tomesphere.com/paper/PMC12970978